logo transparent gif
top_left_edge top_white_spacer top_right_edge
Home Latest Forum Topics MyCorner - Personal Stocks Porfolio Stock Lists Forex Investor Insights Investment News Investor Research & Links Dynamic Stock Charting FREE Registration About Us top spacer top spacer
 User Password Auto-Login
Enter Stock
 
righttip
branding

Return

IX Biopharma

42C

0.076

-0.001

GroupCash
CashSingapore Dollar

 

TRADING INFO


Open
0.077
Buy
0.077
Sell
0.079
High
0.077
Low
0.076
Previous Close
0.077
Volume(K)
95.0
Buy Volume(K)
42.3
Sell Volume(K)
6.8

KEY STOCK INFOUpdated: 21 Mar 2023


PE Ratio (FY)
NA
Dividend Yield % (FY)
-
Price to Book Ratio
-
Market Cap ($million)
-
Enterprise Value ($million)
-
52 Weeks High
0.2
52 Weeks Low
0.075
RSI
20.01 ( Oversold )
Williams %R
-95.12 ( Oversold )

 

COMPANY INFORMATION Updated: 18 Mar 2023 Financial Info by


SIC
IN VITRO AND IN VIVO DIAGNOSTIC SUBSTANCES
Address
105 CECIL STREET #12-02 THE OCTAGON SINGAPORE 068898
Phone
(65) 6235 2170
Fax
(65) 8928 8467
Profile
The principal activities of the Company are the development, manufacture and commercialisation of innovative therapies for the treatment of acute and breakthrough pain, and male erectile dysfunction.
AUDITOR
PRICEWATERHOUSECOOPERS LLP

 

FINANICALS INFORMATION All values in $millions


Financial Year
Jun 30, 2020
Jun 30, 2021
Jun 30, 2022
Currency
SGD
SGD
SGD
KEY RATIOS
FY 2020
FY 2021
FY 2022

Operating Margin(%)
-1041.726
-461.834
-27.081
Return on Equity Capital(%)
-68.471
-75.269
-29.235
Net Profit Margin(%)
-1065.888
-471.862
-31.953
Current Ratio
2.47
2.55
2.144
Debt to Capital at Book
0.231
0.225
0.154
INCOME STATEMENT
FY 2020
FY 2021
FY 2022

EBITDA
-9.68
-8.81
2.33
EBIT
-10.73
-9.86
1.27
Net Profit
-10.5
-8.23
-4.6
Ordinary Dividend
0
0
0
BALANCE SHEET
FY 2020
FY 2021
FY 2022

Intangibles
0.45
0.41
0.35
Fixed Assets
8.03
8.34
7.5
Long Term Investments
0
0
0
Stock/Inventories
0.88
1.1
0.91
Cash
5.66
6.21
13.49
Current Liabilities
3.3
3.67
7.86
Long Term Debt
3.44
3.2
0.88
Provisions
0.06
0.04
0.04
Minorities
0
0
0
Total Shareholder Equity
10.17
11.71
19.74
PER SHARE INFO
FY 2020
FY 2021
FY 2022

EBITDA per share
-0.015
-0.013
0.003
EBIT per share
-0.016
-0.012
-0.005
Profit Per Share
-0.016
-0.012
-0.006
Book Value Per Share
0.015
0.016
0.026

 

 


Intraday Chart




ShareJunction Version: 27 Nov 2020 ver- All Rights Reserved. Copyright ShareJunction Pte. Ltd. Disclaimer: All prices from are delayed. ShareJunction does not provide you with any financial advice. We are not into the business of providing any investment advice. See our Terms and Conditions and Privacy Policy of using this website. Data is delayed for varying periods of time depending on the exchange, but for at least 15 minutes. Copyright SIX Financial Information Ltd. and its licensors. All Rights reserved. Further distribution and use by third parties prohibited. SIX Financial Information and its licensors make no warranty for information displayed and accept no liability for data and prices. SIX Financial Information reserves the right to adapt and/or alter this website at any time without prior notice.

Web design by FoundationFlux.